V260-027 Safety and Immunogenicity of RotaTeq in Elderly Subjects.
Phase of Trial: Phase I
Latest Information Update: 23 Oct 2011
At a glance
- Drugs Rotavirus W179-9 vaccine (Primary)
- Indications Rotavirus infections
- Focus Adverse reactions; Pharmacodynamics
- 23 Oct 2011 Results for part I presented at the 49th Annual Meeting of the Infectious Diseases Society of America.
- 24 Feb 2011 Actual end date (1 Apr 2010) added as reported by ClinicalTrials.gov.
- 22 Apr 2010 Actual patient number changed from 260 to 66 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History